Evidence map›Paper›PMID 36270492›Full record

ArticleThe Journal of allergy and clinical immunology2022

IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn?

Charles F Schuler, Johann E Gudjonsson

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. IL-31/33 Axis in Atopic Dermatitis.International journal of molecular sciences · 2025
    Review
  4. Genetic and Immunological Pathogenesis of Atopic Dermatitis.The Journal of investigative dermatology · 2024
    Review
  5. Review
  6. Repressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Charles F SchulerDivision of Allergy and Clinical Immunology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Mich; Mary H. Weiser Food Allergy Center, Michigan Medicine, University of Michigan, Ann Arbor, Mich.
Johann E GudjonssonDepartment of Dermatology, Michigan Medicine, University of Michigan, Ann Arbor, Mich. Electronic address: johanng@med.umich.edu.

Funding

University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6M
Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of PsoriasisR01AR069071 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2015 to 2019
$2.1M
The role of epithelial barrier dysfunction in food anaphylaxisK23AI162661 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Charles F Schuler · 2022 to 2026
$972k
NIAID NIH HHS K23 AI162661NIAID NIH HHS L30 AI171988NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR069071
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dermatitis, AtopicEczemaHumansInterleukin-33Protein TransportInterleukin-33astegolimabAtopic dermatitisIL-33ST2

Identifiers

PMID36270492
PMCPMC10087095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.